At Veranova, our 20+ years of experience in ADC linker-payload development, purification, and manufacturing is backed by our capabilities for handling highly potent active pharmaceutical ingredients and our world-leading cGMP facilities.

  • Multiple linker-payload systems and diverse polymers
  • Bioconjugation: Expanding capabilities for conjugate development.
  • 50+ years of experience manufacturing cytotoxic APIs
  • Development, scale-up, and clinical and commercial manufacturing of linkers-payloads under one roof
  • Full analytical support for RSM, intermediate and API characterization, and in-process control strategies

To discover how you can get ADC support from clinical to commercial scale, contact us today.

Get in Touch Veranova's ADC Capabilities: Linkers, Payloads, and Conjugates
ADC Molecule

ADC Linker Technology: Advancements & How to Harness Them

Watch our webinar to learn more about the newest classes of linkers and some of the challenges in their synthesis and purification.

Analytical Risk Management in ADC Development

Read our white paper to read about the practical framework for analytical risk management that links discovery labs, pilot facilities, and full-scale plants.

Will sanders presents at SCALE

Flash Chromatography in Clinical ADC Payload-Linker Production

Watch our presentation to explore the critical role of flash chromatography in the development and clinical advancement of increasingly complex ADC payload-linkers.

Veranova is your next great decision

Discover new ways to advance your science with Veranova.

Contact us